Search Results - Pascal Girard

Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants by Orestis Papasouliotis, David Mitchell, Pascal Girard, Martin Dyroff

Connect to this object online.

Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study by Orestis Papasouliotis, David Mitchell, Pascal Girard, Fernando Dangond, Martin Dyroff

Connect to this object online.

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology by Nadia Terranova, Pascal Girard, Konstantinos Ioannou, Ute Klinkhardt, Alain Munafo

Connect to this object online.

Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case Study by Ana‐Marija Grisic, Akash Khandelwal, Mauro Bertolino, Wilhelm Huisinga, Pascal Girard, Charlotte Kloft

Connect to this object online.

Population pharmacokinetics of atacicept in systemic lupus erythematosus: An analysis of three clinical trials by Maria Pitsiu, Özkan Yalkinoglu, Colm Farrell, Pascal Girard, Cristina Vazquez‐Mateo, Orestis Papasouliotis

Connect to this object online.

Predicting disease activity in patients with multiple sclerosis: An explainable machine‐learning approach in the Mavenclad trials by Sreetama Basu, Alain Munafo, Ali‐Frederic Ben‐Amor, Sanjeev Roy, Pascal Girard, Nadia Terranova

Connect to this object online.

Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model‐based dose-toxicity models by Kristyn Pantoja, Shankar Lanke, Alain Munafo, Anja Victor, Christina Habermehl, Armin Schueler, Karthik Venkatakrishnan, Pascal Girard, Kosalaram Goteti

Connect to this object online.

Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose by Wenyuan Xiong, Manja Friese‐Hamim, Andreas Johne, Christopher Stroh, Manfred Klevesath, Gerald S. Falchook, David S. Hong, Pascal Girard, Samer El Bawab

Connect to this object online.

Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non‐small cell lung cancer based on bintrafusp alfa trials by Ana‐Marija Milenković‐Grišić, Nadia Terranova, Diane R. Mould, Yulia Vugmeyster, Thomas Mrowiec, Andreas Machl, Pascal Girard, Karthik Venkatakrishnan, Akash Khandelwal

Connect to this object online.

Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma by Justin J. Wilkins, Brigitte Brockhaus, Haiqing Dai, Yulia Vugmeyster, Joleen T. White, Satjit Brar, Carlo L. Bello, Berend Neuteboom, Janet R. Wade, Pascal Girard, Akash Khandelwal

Connect to this object online.

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer by Han Liu, Ana‐Marija Milenković‐Grišić, Sreenath M. Krishnan, Siv Jönsson, Lena E. Friberg, Pascal Girard, Karthik Venkatakrishnan, Yulia Vugmeyster, Akash Khandelwal, Mats O. Karlsson

Connect to this object online.

Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab by Nadia Terranova, Jonathan French, Haiqing Dai, Matthew Wiens, Akash Khandelwal, Ana Ruiz‐Garcia, Juliane Manitz, Anja vonHeydebreck, Mary Ruisi, Kevin Chin, Pascal Girard, Karthik Venkatakrishnan

Connect to this object online.

Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient‐level placebo (Standard‐of‐Care) data... by Kosalaram Goteti, Jonathan French, Ramon Garcia, Ying Li, Florence Casset‐Semanaz, Aida Aydemir, Robert Townsend, Cristina Vazquez Mateo, Matthew Studham, Oliver Guenther, Amy Kao, Marc Gastonguay, Pascal Girard, Lisa Benincosa, Karthik Venkatakrishnan

Connect to this object online.

Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy by Perrine Courlet, Daniel Abler, Monia Guidi, Pascal Girard, Federico Amato, Naik Vietti Violi, Matthieu Dietz, Nicolas Guignard, Alexandre Wicky, Sofiya Latifyan, Rita De Micheli, Mario Jreige, Clarisse Dromain, Chantal Csajka, John O. Prior, Karthik Venkatakrishnan, Olivier Michielin, Michel A. Cuendet, Nadia Terranova

Connect to this object online.